Dogecoin Cash operates PrestoDoctor, a telemedicine platform that connects patients with licensed independent physicians for medical cannabis evaluations. Patients in states where medical cannabis is legal can schedule a remote video consultation, get evaluated, and obtain a medical cannabis recommendation — without visiting a clinic. PrestoDoctor acts as a marketplace: it provides the technology and administrative infrastructure, while independent physicians conduct the actual consultations. The company runs an asset-light model, avoiding the costs of owning clinics or directly employing physicians. Revenue is generated almost entirely from consultation fees, and growth depends on consultation volume, which is driven by the number of states with legal medical cannabis, the size of the patient population seeking evaluations, and PrestoDoctor's ability to attract patients and physicians to its platform. Beyond its core telemedicine business, Dogecoin Cash holds several ancillary subsidiaries in digital assets and cryptocurrency, as well as cannabis-related intellectual property through Kubby Patent and Licenses — neither of which currently generates meaningful revenue. Despite the company's name and its subsidiaries' branding, Dogecoin Cash has no affiliation with the Dogecoin cryptocurrency.